Evaluation of repRNA vaccine for induction and in utero transfer of maternal antibodies in a pregnant rabbit model-Reference-Cited by-同舟云学术

Evaluation of repRNA vaccine for induction and in utero transfer of maternal antibodies in a pregnant rabbit model

Published:2023-04 Issue:4 Volume:31 Page:1046-1058
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Khandhar Amit P.^ORCID,Landon Chelsea D.,Archer Jacob,Krieger Kyle,Warner Nikole L.,Randall Samantha,Berube Bryan J.,Erasmus Jesse H.,Sather D. Noah,Staats Herman F.

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference30 articles.

1. Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons;Shimabukuro;N. Engl. J. Med.,2021

2. Enhancement of protein expression by alphavirus replicons by designing self-replicating subgenomic RNAs;Kim;Proc. Natl. Acad. Sci. USA,2014

3. Self-amplifying RNA vaccines give equivalent protection against influenza to mRNA vaccines but at much lower doses;Vogel;Mol. Ther.,2018

4. Intramuscular delivery of replicon RNA encoding ZIKV-117 human monoclonal antibody protects against zika virus infection;Erasmus;Mol. Ther. Methods Clin. Dev.,2020

5. Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial;Pollock;EClinicalMedicine,2021

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A self-amplifying RNA vaccine prevents enterovirus D68 infection and disease in preclinical models;Science Translational Medicine;2024-08-07

2. A gH/gL-encoding replicon vaccine elicits neutralizing antibodies that protect humanized mice against EBV challenge;npj Vaccines;2024-06-26

3. A polyvalent RNA vaccine reduces the immune imprinting phenotype in mice and induces neutralizing antibodies against omicron SARS-CoV-2;Heliyon;2024-02

4. RECENT PROGRESS IN ANTIVIRALS AGAINST ZIKA VIRUS;Medicinal Chemistry Reviews;2023-11-16

5. A localizing nanocarrier formulation enables multi-target immune responses to multivalent replicating RNA with limited systemic inflammation;Molecular Therapy;2023-08